中國2015年麻疹風疹實驗室網(wǎng)絡運轉與評價
[Abstract]:Objective to evaluate the operation of measles rubella laboratory network (Measles/rubella laboratory network,MRLN) in China (excluding Hong Kong, Macao Special Administrative region and Taiwan) in 2015. Methods the laboratory data of China measles Surveillance Information report Management system in 2015 and the national MRLN monitoring data were analyzed by descriptive epidemiology method. The indexes of MRLN operation in China were evaluated. Results A total of 104 948 surveillance cases were reported in 2015, of which 42 382 were measles cases, 40 717 (96.07%) were laboratory confirmed cases, 8 143 were rubella cases and 6 324 (77.66%) were laboratory confirmed cases. A total of 400 outbreaks were reported, including 329 measles outbreaks and 31 rubella outbreaks. A total of 90,305 blood samples were collected, and the positive rates of measles and rubella IgM were 38.75 and 6.30 respectively. A total of 45 032 pathogenic specimens were collected from sporadic surveillance cases, and the collection rate was 48. 60%. The positive rate of nucleic acid detection of measles and rubella virus was 35.745.43.29 provincial measles rubella laboratory (Measles/rubella laboratory,MRL), a total of 3,967 measles virus strains were tested, among which 1 strain of Dap9 gene subtype was detected. 16 strains of genotype A (vaccine related strain), 3 950 strains of H1a gene subtype endemic in China, were tested for rubella virus 316 strains with 16 provincial MRL, including 4 strains of genotype 1E and 312 strains of genotype 2B. National MRL and 32 provincial MRL all passed the World Health Organization's functional examination in 2015. Conclusion the MRLN of China in 2015 is working well, which confirms that the epidemic of local measles genotype H1 is still circulating, which provides a good laboratory network support for the elimination of measles in China.
【作者單位】: 中國疾病預防控制中心病毒病預防控制所國家衛(wèi)生和計劃生育委員會醫(yī)學病毒學和病毒病重點實驗室世界衛(wèi)生組織西太平洋區(qū)麻疹參比實驗室;
【基金】:國家自然科學基金課題(項目號81371791) 麻疹疾控專項經(jīng)費(2015年) 行使WHO西太區(qū)地區(qū)麻疹風疹參比實驗室職能(CHN-15-EPI-002033)
【分類號】:R511
【相似文獻】
相關期刊論文 前10條
1 馬麗莉;2000~2001年全球消滅脊髓灰質炎實驗室網(wǎng)絡的重大貢獻[J];中國計劃免疫;2002年06期
2 祝雙利;王東艷;張勇;李杰;嚴冬梅;朱暉;安洪秋;陳立;許文波;;中國2007年脊髓灰質炎實驗室網(wǎng)絡的運轉與評價[J];中國疫苗和免疫;2008年06期
3 張勇;李杰;祝雙利;嚴冬梅;朱暉;安洪秋;王東艷;陳立;許文波;;中國2006年脊髓灰質炎實驗室網(wǎng)絡的運轉與監(jiān)測[J];中國計劃免疫;2007年06期
4 嚴冬梅;;全球脊髓灰質炎實驗室網(wǎng)絡非正式磋商會議[J];中國疫苗和免疫;2008年06期
5 李杰,祝雙利,張勇,趙蓉,侯曉輝,王東艷,陳立,張禮璧,溫寧,徐濤,許文波;中國2002年脊髓灰質炎實驗室網(wǎng)絡的運轉與監(jiān)測[J];中國計劃免疫;2003年05期
6 朱貞;;2007年麻疹/風疹實驗室網(wǎng)絡會議:使用替代標本采樣技術用于監(jiān)測[J];中國疫苗和免疫;2008年06期
7 蔣巖;我國艾滋病實驗室網(wǎng)絡、檢測技術及其質量保證體系進展[J];科技導報;2005年07期
8 侯雪芹;;廣元市艾滋病實驗室網(wǎng)絡建設及運行現(xiàn)狀調查[J];現(xiàn)代預防醫(yī)學;2013年13期
9 王東艷;祝雙利;張勇;朱暉;張波;李曉嫘;嚴冬梅;安洪秋;檀曉娟;許文波;;中國2012年脊髓灰質炎實驗室網(wǎng)絡的運轉與評價[J];中國疫苗和免疫;2014年03期
10 馬學軍;;通化市艾滋病實驗室網(wǎng)絡體系建設情況及檢測能力分析[J];中國當代醫(yī)藥;2012年28期
,本文編號:2412496
本文鏈接:http://www.sikaile.net/yixuelunwen/chuanranbingxuelunwen/2412496.html